Literature DB >> 11509118

Detection and cloning of a protein recognized by anti-human prostate-specific antigen (PSA) antibody in the rat ventral prostate.

M Onozawa1, K Fukuda, M Watanabe, M Ohtani, H Akaza, T Sugimura, K Wakabayashi.   

Abstract

Prostate-specific antigen (PSA), a 33 kDa glycoprotein produced in the epithelium of the human prostate, has become established as a useful tumor marker for prostate cancer in man. Since reports of homologous proteins in animals other than primates have been lacking, the present investigation was carried out to identify any PSA-like protein in rats. Immunoblot analysis using a specific monoclonal anti-human PSA antibody detected a 32 kDa immunoreactive protein in the ventral lobe of the rat prostate, but not in other lobes or in other tissues. Positive immunostaining was observed only for the luminal surface of the glandular epithelium and the intraductal fluid in the ventral prostate. Sequence analysis of a cDNA for the rat PSA-like protein, cloned by immunoscreening of an expression cDNA library prepared from the ventral lobe, revealed identity to the rat submaxillary gland S3 kallikrein. Human PSA also belongs to the kallikrein family. Thus, this protein produced in the rat ventral prostate was suggested to be a possible counterpart of human PSA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11509118      PMCID: PMC5926826          DOI: 10.1111/j.1349-7006.2001.tb01173.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  26 in total

1.  Human prostate-specific antigen: structural and functional similarity with serine proteases.

Authors:  K W Watt; P J Lee; T M'Timkulu; W P Chan; R Loor
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

2.  A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein.

Authors:  H Lilja
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

3.  A five-alpha reductase inhibitor or an antiandrogen prevents the progression of microscopic prostate carcinoma to macroscopic carcinoma in rats.

Authors:  S Tsukamoto; H Akaza; M Onozawa; T Shirai; Y Ideyama
Journal:  Cancer       Date:  1998-02-01       Impact factor: 6.860

Review 4.  [Treatment for hormone-refractory or relapsing prostatic cancer].

Authors:  Y Hirao; S Ozono; E Okajima
Journal:  Gan To Kagaku Ryoho       Date:  1996-03

5.  Prostate marker immunoreactivity in salivary gland neoplasms. A rare pitfall in immunohistochemistry.

Authors:  J H van Krieken
Journal:  Am J Surg Pathol       Date:  1993-04       Impact factor: 6.394

6.  Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.

Authors:  T Ishikawa; H Kashiwagi; Y Iwakami; M Hirai; T Kawamura; Y Aiyoshi; T Yashiro; Y Ami; K Uchida; M Miwa
Journal:  Jpn J Clin Oncol       Date:  1998-12       Impact factor: 3.019

7.  Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overestimation.

Authors:  A A Elgamal; N L Ectors; S Sunardhi-Widyaputra; H P Van Poppel; B J Van Damme; L V Baert
Journal:  J Urol       Date:  1996-08       Impact factor: 7.450

Review 8.  Combination therapy for prostate cancer. Endocrine and biologic basis of its choice as new standard first-line therapy.

Authors:  F Labrie; A Belanger; J Simard; C Labrie; A Dupont
Journal:  Cancer       Date:  1993-02-01       Impact factor: 6.860

Review 9.  Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era.

Authors:  R T McCormack; H G Rittenhouse; J A Finlay; R L Sokoloff; T J Wang; R L Wolfert; H Lilja; J E Oesterling
Journal:  Urology       Date:  1995-05       Impact factor: 2.649

10.  The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line.

Authors:  J F Karr; J A Kantor; P H Hand; D L Eggensperger; J Schlom
Journal:  Cancer Res       Date:  1995-06-01       Impact factor: 12.701

View more
  3 in total

1.  Red ginseng and 20(S)-Rg3 control testosterone-induced prostate hyperplasia by deregulating androgen receptor signaling.

Authors:  Jung-Soo Bae; Hyoung-Sook Park; Jong-Wan Park; Shan-Hua Li; Yang-Sook Chun
Journal:  J Nat Med       Date:  2011-11-20       Impact factor: 2.343

2.  Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase.

Authors:  Dong-Hyun Youn; Jinbong Park; Hye-Lin Kim; Yunu Jung; JongWook Kang; Mi-Young Jeong; Gautam Sethi; Kwang Seok Ahn; Jae-Young Um
Journal:  Oncotarget       Date:  2017-02-07

3.  Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase.

Authors:  Hyun-Myung Choi; Yunu Jung; Jinbong Park; Hye-Lin Kim; Dong-Hyun Youn; JongWook Kang; Mi-Young Jeong; Jong-Hyun Lee; Woong Mo Yang; Seok-Geun Lee; Kwang Seok Ahn; Jae-Young Um
Journal:  Sci Rep       Date:  2016-08-23       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.